These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17520094)

  • 21. Poly ADP-ribose polymerase-1 and health.
    Kirkland JB
    Exp Biol Med (Maywood); 2010 May; 235(5):561-8. PubMed ID: 20463295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly(ADP-ribose) polymerase activation in the reperfused myocardium.
    Szabó G; Liaudet L; Hagl S; Szabó C
    Cardiovasc Res; 2004 Feb; 61(3):471-80. PubMed ID: 14962478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(ADP-ribose) and carcinogenesis.
    Masutani M; Nakagama H; Sugimura T
    Genes Chromosomes Cancer; 2003 Dec; 38(4):339-48. PubMed ID: 14566854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poly(ADP-Ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure.
    Xiao CY; Chen M; Zsengellér Z; Li H; Kiss L; Kollai M; Szabó C
    J Pharmacol Exp Ther; 2005 Mar; 312(3):891-8. PubMed ID: 15523000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PARP inhibitors: new tools to protect from inflammation.
    Giansanti V; Donà F; Tillhon M; Scovassi AI
    Biochem Pharmacol; 2010 Dec; 80(12):1869-77. PubMed ID: 20417190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A scintillation proximity assay for poly(ADP-ribose) polymerase.
    Cheung A; Zhang J
    Anal Biochem; 2000 Jun; 282(1):24-8. PubMed ID: 10860495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of poly(ADP-ribose) polymerase increase antibody class switching.
    Shockett P; Stavnezer J
    J Immunol; 1993 Dec; 151(12):6962-76. PubMed ID: 8258703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by reactive oxidant hydrogen peroxide in vitro.
    Radovits T; Lin LN; Zotkina J; Gero D; Szabó C; Karck M; Szabó G
    Eur J Pharmacol; 2007 Jun; 564(1-3):158-66. PubMed ID: 17397824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential contribution of poly(ADP-ribose)polymerase-1 and -2 (PARP-1 and -2) to the poly(ADP-ribosyl)ation reaction in rat primary spermatocytes.
    Tramontano F; Malanga M; Quesada P
    Mol Hum Reprod; 2007 Nov; 13(11):821-8. PubMed ID: 17766683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly(ADP-ribose) polymerase-1 in the nervous system.
    Ha HC; Snyder SH
    Neurobiol Dis; 2000 Aug; 7(4):225-39. PubMed ID: 10964595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(ADP-ribose) polymerase inhibitors as potential chemotherapeutic agents.
    Bryant HE; Helleday T
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):959-61. PubMed ID: 15506935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks.
    Smith LM; Willmore E; Austin CA; Curtin NJ
    Clin Cancer Res; 2005 Dec; 11(23):8449-57. PubMed ID: 16322308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells.
    Kehe K; Raithel K; Kreppel H; Jochum M; Worek F; Thiermann H
    Arch Toxicol; 2008 Jul; 82(7):461-70. PubMed ID: 18046540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(ADP-ribose) polymerase: a new therapeutic target?
    Gerö D; Szabó C
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):111-21. PubMed ID: 18443476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poly(ADP-Ribose) polymerase inhibition improves endothelial dysfunction induced by hypochlorite.
    Radovits T; Zotkina J; Lin LN; Bömicke T; Arif R; Gerö D; Horváth EM; Karck M; Szabó C; Szabó G
    Exp Biol Med (Maywood); 2007 Oct; 232(9):1204-12. PubMed ID: 17895528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of independent mechanism upon poly(ADP-ribose) polymerase (PARP) activation in methylmercury cytotoxicity in rat cerebellar granule cell culture.
    Sakaue M; Mori N; Okazaki M; Ishii M; Inagaki Y; Iino Y; Miyahara K; Yamamoto M; Kumagai T; Hara S; Yamamoto M; Arishima K
    J Neurosci Res; 2008 Nov; 86(15):3427-34. PubMed ID: 18627028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of poly(ADP-ribosylation) in apoptotic cells.
    Ivana Scovassi A; Diederich M
    Biochem Pharmacol; 2004 Sep; 68(6):1041-7. PubMed ID: 15313399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.
    Komjáti K; Besson VC; Szabó C
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):179-94. PubMed ID: 15857303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly (ADP) ribose polymerase inhibition improves rat cardiac allograft survival.
    Farivar AS; McCourtie AS; MacKinnon-Patterson BC; Woolley SM; Barnes AD; Chen M; Jagtap P; Szabó C; Salerno CT; Mulligan MS
    Ann Thorac Surg; 2005 Sep; 80(3):950-6. PubMed ID: 16122462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.